chr11-66070569-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_018026.4(PACS1):​c.83C>G​(p.Ser28Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000223 in 1,478,700 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 1 hom. )

Consequence

PACS1
NM_018026.4 missense

Scores

2
1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.94

Publications

1 publications found
Variant links:
Genes affected
PACS1 (HGNC:30032): (phosphofurin acidic cluster sorting protein 1) This gene encodes a protein with a putative role in the localization of trans-Golgi network (TGN) membrane proteins. Mouse and rat homologs have been identified and studies of the homologous rat protein indicate a role in directing TGN localization of furin by binding to the protease's phosphorylated cytosolic domain. In addition, the human protein plays a role in HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the TGN, thereby enabling HIV-1 to escape immune surveillance. [provided by RefSeq, Jul 2008]
PACS1 Gene-Disease associations (from GenCC):
  • Schuurs-Hoeijmakers syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008917958).
BP6
Variant 11-66070569-C-G is Benign according to our data. Variant chr11-66070569-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 211816.
BS2
High AC in GnomAd4 at 19 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PACS1NM_018026.4 linkc.83C>G p.Ser28Cys missense_variant Exon 1 of 24 ENST00000320580.9 NP_060496.2 Q6VY07-1A0A024R5H6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PACS1ENST00000320580.9 linkc.83C>G p.Ser28Cys missense_variant Exon 1 of 24 1 NM_018026.4 ENSP00000316454.4 Q6VY07-1

Frequencies

GnomAD3 genomes
AF:
0.000119
AC:
18
AN:
151532
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000443
Gnomad OTH
AF:
0.000480
GnomAD2 exomes
AF:
0.000689
AC:
57
AN:
82706
AF XY:
0.000805
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000337
Gnomad OTH exome
AF:
0.000420
GnomAD4 exome
AF:
0.000234
AC:
311
AN:
1327058
Hom.:
1
Cov.:
31
AF XY:
0.000316
AC XY:
207
AN XY:
654414
show subpopulations
African (AFR)
AF:
0.0000373
AC:
1
AN:
26842
American (AMR)
AF:
0.00
AC:
0
AN:
28646
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23118
East Asian (EAS)
AF:
0.0000349
AC:
1
AN:
28666
South Asian (SAS)
AF:
0.00336
AC:
247
AN:
73480
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33638
Middle Eastern (MID)
AF:
0.000743
AC:
3
AN:
4040
European-Non Finnish (NFE)
AF:
0.0000437
AC:
46
AN:
1053504
Other (OTH)
AF:
0.000236
AC:
13
AN:
55124
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000125
AC:
19
AN:
151642
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74116
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5108
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0000443
AC:
3
AN:
67740
Other (OTH)
AF:
0.000475
AC:
1
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.000285
AC:
24

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 21, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
May 16, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

PACS1-related disorder Benign:1
Sep 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
23
DANN
Benign
0.96
DEOGEN2
Benign
0.023
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.25
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.48
T
M_CAP
Uncertain
0.15
D
MetaRNN
Benign
0.0089
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L
PhyloP100
2.9
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.27
N
REVEL
Benign
0.053
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.085
T
Polyphen
0.90
P
Vest4
0.24
MutPred
0.19
Loss of phosphorylation at S28 (P = 0.0174);
MVP
0.15
MPC
1.4
ClinPred
0.19
T
GERP RS
2.9
PromoterAI
-0.0060
Neutral
Varity_R
0.24
gMVP
0.17
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs763294619; hg19: chr11-65838040; API